Furthermore, we found cell cycle inhibition to correlate with down‐regulation of cyclin D1 and cyclin A. In summary, our study shows that PTL and DMAPT have a strong inhibitory effect on CML cells. Here, CCNA2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.